Can Breast Cancer Patients Survive Long-Term Without Surgery?
For many people, surgery has long been viewed as the
essential step in curing cancer. The common belief is simple: if the tumor can
be removed, there is hope for a cure. However, advances in modern cancer
therapy are beginning to challenge this traditional view.
With the rapid development of neoadjuvant therapy —
treatment given before surgery — some breast cancer patients are achieving
remarkable responses. In certain cases, tumors completely disappear after drug
treatment alone, raising an important question: If no cancer can be found, is
surgery always necessary?
A recent study led by MD Anderson Cancer Center explored
this possibility in patients with early-stage breast cancer. The study focused
on patients with triple-negative breast cancer or HER2-positive breast cancer
who had undergone standard neoadjuvant therapy.
After treatment, researchers performed image-guided needle
biopsies of both the original tumor site and surrounding lymph nodes. Among the
50 patients enrolled in the study, 31 achieved a pathological complete response
(pCR), meaning no remaining cancer cells could be detected in the biopsy
samples.
Instead of proceeding directly to surgery, these 31 patients
received whole-breast radiation therapy alone. After a median follow-up period
of 26.4 months, none of the patients experienced cancer recurrence, and the
recurrence-free survival rate remained 100%.
The lead investigator, Dr. Henry Kuerer, described this
approach as the ‘ultimate form of breast-conserving therapy,’ where cancer may
potentially be eradicated using systemic therapy without the need for surgery.
At the same time, researchers emphasized that this strategy
is still experimental. Standard breast cancer surgery remains the current
recommended treatment. Longer follow-up and larger clinical studies are still
needed before surgery-free treatment can become part of routine clinical
practice.
Even so, the study highlights how rapidly cancer treatment
is evolving. Advances in chemotherapy, targeted therapy, immunotherapy, and
imaging are increasingly allowing physicians to tailor treatment to individual
patients. In the future, some patients may be able to avoid surgery altogether
while still achieving excellent long-term outcomes.
Reference Study
Kuerer HM et al.
“Eliminating breast surgery for invasive breast cancer in exceptional
responders to neoadjuvant systemic therapy.” The Lancet Oncology (2023).
Study link: https://pubmed.ncbi.nlm.nih.gov/36856291/
This article is intended for educational and informational
purposes only and should not be considered medical advice. Patients should
always discuss treatment decisions with qualified medical professionals.

Comments
Post a Comment